New JP Draft 2.28 Circular Dichroism Spectroscopy Published for Public Comments
Recommendation

3/4 February 2026
Evaluation, Implementation and Use of Suitable Technologies
The Japanese Pharmaceuticals and Medical Devices Agency (PMDA) has published a Japanese Pharmacopoeia (JP) draft of a New General Test 2.28 Circular Dichroism Spectroscopy.
The chapter starts with a short introduction to the topic and an explanation of the relevant equations and definitions. The method is defined as follows:
The circular dichroism spectroscopy is a method used to analyze and determine the structure of optically active substances, discriminate active substances from enantiomers, diastereomers, etc by using the phenomenon (circular dichroism) in which the degrees of absorption of left and right circularly polarized lights differ in the absorption wave length region of active substances.
After the general introduction, the new chapter is divided into the following chapters and subchapters:
- 1. Apparatus
- 2. Methods
2.1. Identification test
2.2. Analysis of secondary structure - 3. Verification of the performance of apparatus
3.1. Accuracy of circular dichroism
3.2. Linearity of modulation
The draft document is available as a PDF file on the PMDA's website. Comments can be submitted until September 30, 2021. For this purpose, a form for comments has to be downloaded and sent by e-mail after it has been filled in.
Related GMP News
15.12.2025FDA Warning Letter Criticises Handling of OOS Results at a Contract Laboratory
15.12.2025FDA Warning: No Recall Conducted Despite Confirmed Benzene Impurity
10.12.2025FDA Warning Letter: 1,500 OOS Results with Numerous Inadequate Investigations
26.11.2025FDA Warning Letter Highlights Deficiencies in SST and HPLC Practices
13.11.2025Proposed Revision of USP <1225> Published in the Pharmacopeial Forum


